Recomendaciones para el estudio genético de la pareja con alteraciones en la reproducción

Revista del Laboratorio Clínico - Tập 2 - Trang 196-203 - 2009
Concepción Alonso Cerezo1,2, María Carmen Cañadas Gálvez3,4, Luis Alfonso de la Fuente Hernández5,6, Carlos García-Ochoa7,8, José Miguel García Sagredo9, Victoria González Villafáñez3,10, Mercedes Marcos González11,12, Rafael Oliva Virgili13, María Orera Clemente14,15
1Asociación Española de Biopatología Médica, España
2Unidad de Genética, Servicio de Análisis Clínicos, Hospital Universitario de la Princesa, Madrid, España
3Sociedad Española de Ginecología y Obstetricia, Madrid, España
4Laboratorio de Fecundación in Vitro, Clínica GINEFIV, Madrid, España
5Sociedad Española de Fertilidad, España
6Instituto Europeo de Fertilidad, Madrid, España
7Asociación Española de Andrología, España
8Centro de Fertilización in Vitro de Asturias (CEFIVA), Oviedo, España
9Servicio de Genética Médica, Hospital Universitario Ramón y Cajal, Madrid, España
10Unidad de Ginecología, Clinica GINEFIV, Madrid, España
11Sociedad Española de Bioquímica Clínica y Patología Molecular, España
12Laboratorio de Andrología, Hospital Universitario La Paz, Madrid, España
13Servicio de Genética, Hospital Clínic, Barcelona, España
14Asociación Española de Genética Humana, España
15Unidad de Genética, Hospital Universitario Gregorio Marañón, Madrid, España

Tài liệu tham khảo

Infertility revisited: The state of the art today and tomorrow. The ESHRE Capri Workshop. European Society for Human Reproduction and Embryology. Hum Reprod 1996; 11: 1779–807. Greenhall, 1990, The prevalence of subfertility: A review of the current confusion and a report of two new studies, Fertil Steril, 54, 978, 10.1016/S0015-0282(16)53990-9 De Kretser, 1997, Male infertility, Lancet, 349, 787, 10.1016/S0140-6736(96)08341-9 Healy, 1994, Female infertility: Causes and treatment, Lancet, 343, 1539, 10.1016/S0140-6736(94)92941-6 Foresta, 2002, Guidelines for the appropriate use of genetic tests in infertile couples, Eur J Hum Genet, 10, 303, 10.1038/sj.ejhg.5200805 Ley de Investigación Biomédica. L. 14/2007 de 3 de julio. Boletín Oficial del Estado. N.o 159, (Jul. 4, 2007). Nussbaum RL, McInnes RR, Willard HF. Principles of clinical cytogenetics. En: Thompson & Thompson. Genetics in medicine, 6th ed. Philadelphia: WB Saunders; 2004. p. 135–55. Schreurs, 2000, Increased frequency of chromosomal abnormalities in female partners of couples undergoing in vitro fertilization or intracytoplasmic sperm injection, Fertil Steril, 74, 94, 10.1016/S0015-0282(00)00558-6 Gekas, 2001, Chromosomal factors of infertility in candidate couples for ICSI: An equal risk of constitutional aberrations in women and men, Hum Reprod, 16, 82, 10.1093/humrep/16.1.82 Papanikolaou, 2005, Is chromosome analysis mandatory in the initial investigation of normovulatory women seeking infertility treatment?, Hum Reprod, 20, 2899, 10.1093/humrep/dei151 Riccaboni, 2008, Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: Results of application of Italian guidelines for the appropriate use of genetic tests, Fertil Steril, 89, 800, 10.1016/j.fertnstert.2007.04.032 Mckinlay Gardner RJ, Sutherland GR. The origins and consequences of chromosome pathology. En: Chromosome abnormalities and genetic counselling. 3rd ed. New York: Oxford University Press; 2004. p 21–49. Bondy, 2007, Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group, J Clin Endocrinol Metab, 92, 10, 10.1210/jc.2006-1374 Simpson JL, Bombard A. Chromosomal abnormalities in spontaneous abortion: Frequency, pathology and genetic counselling. En: Bennett MJ, Edmonds DK, editores. Spontaneous and recurrent abortion. Oxford: Blackwell Scientific; 1987. p. 51–76. Soini, 2006, The interface between assisted reproductive technologies and genetics: Technical, social, ethical and legal issues, Eur J Hum Genet, 14, 588, 10.1038/sj.ejhg.5201598 Lewis-Jones, 2000, Cystic fibrosis in infertility: Screening before assisted reproduction: Opinion, Hum Reprod, 15, 2415, 10.1093/humrep/15.11.2415 Castellani, 2008, Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice, J Cyst Fibros, 7, 179, 10.1016/j.jcf.2008.03.009 Dequeker, 2009, Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders - updated European recommendations, Eur J Hum Genet, 17, 51, 10.1038/ejhg.2008.136 Bretherick, 2005, FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure, Hum Genet, 117, 376, 10.1007/s00439-005-1326-8 Machado-Ferreira MC, Costa-Lima MA, Boy RT, Esteves GS, Pimentel MMG. Premature ovarian failure and FRAXA premutation: Positive correlation in a Brazilian survey. Am J Med Genet A. 2004;126A:237–40. Allingham-Hawkins, 1999, Fragile X premutation is a significant risk factor for premature ovarian failure: The international collaborative POF in fragile X study-preliminary data, Am J Med Genet, 83, 322, 10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B Rosendaal, 1998, Geographic distribution of the 20210 G to A prothrombin variant, Thromb Haemost, 79, 706, 10.1055/s-0037-1615049 Press, 2002, Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders, Arch Pathol Lab Med, 126, 1304, 10.5858/2002-126-1304-CUOFVL Laurino, 2005, Genetic evaluation and counselling of couples with recurrent miscarriage: Recommendations of the National Society of Genetic Counselors, J Genet Couns, 14, 165, 10.1007/s10897-005-3241-5 Nelen, 2000, Hyperhomocysteinemia and recurrent early pregnancy loss: A meta-analysis, Fertil Steril, 74, 1196, 10.1016/S0015-0282(00)01595-8 Powers, 2003, The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy, Obstet Gynecol, 101, 762, 10.1016/S0029-7844(02)03120-4 Chandley, 1998, Chromosome anomalies and Y chromosome microdeletions as causal factors in male infertility, Hum Reprod, 13, 45, 10.1093/humrep/13.suppl_1.45 Peshka, 1999, Type and frequency of chromosome aberrations in 781 couples undergoing intracytoplasmic sperm injection, Hum Reprod, 14, 2257, 10.1093/humrep/14.9.2257 Egozcue, 2000, Human male infertility: Chromosome abnormalities, meiotic disorders, abnormal spermatozoa and recurrent abortion, Hum Reprod Update, 6, 93, 10.1093/humupd/6.1.93 Blau, 2002, Urogenital abnormalities in male children with cystic fibrosis, Arch Dis Child, 87, 135, 10.1136/adc.87.2.135 Oliva, 1998, Prevalence of Y chromosome microdeletions in oligospermic and azoospermic candidates for intracytoplasmic sperm injection, Fertil Steril, 70, 506, 10.1016/S0015-0282(98)00195-2 Simoni, 2004, EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions. State of the art 2004, Int J Androl, 27, 240, 10.1111/j.1365-2605.2004.00495.x Bhasin, 2007, Approach to the infertile man, J Clin Endocrinol Metab, 92, 1995, 10.1210/jc.2007-0634 Carrell, 2008, The clinical implementation of sperm chromosome aneuploidy testing: Pitfalls and promises, J Androl, 29, 124, 10.2164/jandrol.107.003699 Hassold, 1996, Human aneuploidy: Incidence, origin and etiology, Environ Mol Mutagen, 28, 167, 10.1002/(SICI)1098-2280(1996)28:3<167::AID-EM2>3.0.CO;2-B Ferguson, 2007, Abnormal meiotic recombination in infertile men and its association with sperm aneuploidy, Hum Mol Genet, 16, 2870, 10.1093/hmg/ddm246 Egozcue, 2005, Meiotic abnormalities in infertile males, Cytogenet Genome Res, 111, 337, 10.1159/000086907 2008, The clinical utility of sperm DNA integrity testing, Fertil Steril, 90, S178, 10.1016/j.fertnstert.2008.08.054